Catalyst Oncology

Oncology market is witnessing considerable growth and attracting large investments from many big pharmaceutical companies to increase their presence. Pfizer ( PFE ) aims big in the oncology market, which is mainly dominated by Roche and expects its global medicine sale for cancer to increase ten-fold by 2018. The company plans to become the third largest player (from current seventh) in cancer medicine, which contributed about $2.5 billion of sales in 2008. At present, many of its products u

View original post here: 
Pfizer Aims Big in Oncology – Analyst Blog